News
When it comes to tackling pancreatic cancer, one of the most challenging and aggressive forms of cancer, people are increasingly exploring alternative therapies alongside conventional treatments. Imagine a protocol that combines cutting-edge science, natural compounds, and a holistic approach—all with the goal of empowering your journey to wellness. Here, we’ll break down an exciting protocol involving fenbendazole, ivermectin, cannabinoids like CBG and full-spectrum extracts.
Continue reading
Cannabidiol (CBD) and cannabigerol (CBG) are increasingly studied for their therapeutic applications in neurological and vision-related conditions. While lower doses (20–300 mg/day) are effective for mild to moderate symptoms, emerging research suggests high doses (600–1000 mg/day) may provide amplified benefits for certain conditions. Let’s dive into the science supporting these high-dose treatments and their specific applications.
Continue reading
CBD is an exciting new integrative, plant-based, sustainable option for those struggling with any of the aforementioned chronic conditions, as well as many more. By exploring the science behind CBD’s interaction with neurotransmitters we are becoming increasingly less dependent on pharmaceuticals and more enlightened about the options that come from nature.
CBD has the ability to bind a variety of neurotransmitter receptors in the brain and nervous system and has a varied array of effects. This allows for potentially new treatment methods that could be able to complement current therapies and replace options are not proving effective; or carry a laundry list of side effects.
Does CBD cure cancer? No, but the science shows it does kill cancer causing cells, make them more sensitive to radiation treatment, stop them from creating a vascular system, and help alleviate the symptoms of these harsh treatments- improving overall health and quality of life. #cancersucks but living with it doesn’t have to. Contact us for compassionate patient pricing. #karmanotpharma
Continue reading
